Back
JPMorgan BetaBuilders US Mid Cap Eq ETF Vs. Neurogene Industry Stock Comparison
Buy
73
BBMC
JPMorgan BetaBuilders US Mid Cap Eq ETF
Last Price:
101.23
Seasonality Move:
8.21%
Sell
1
NGNE
Neurogene
Last Price:
34.67
Seasonality Move:
50.43%
Buy
73
JPMorgan BetaBuilders US Mid Cap Eq ETF (BBMC)
is a Buy
Is JPMorgan BetaBuilders US Mid Cap Eq ETF a Buy, Sell or Hold?
- The current JPMorgan BetaBuilders US Mid Cap Eq ETF [BBMC] share price is $98.96. The Score for BBMC is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- BBMC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
1
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BBMC Stock Price Chart
What is JPMorgan BetaBuilders US Mid Cap Eq ETF's stock price today?
-
The JPMorgan BetaBuilders US Mid Cap Eq ETF share price today is $98.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBMC is experiencing slight selling pressure.
BBMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.65 | Buy |
| Relative Strength Index (14 RSI): | 57.14 | Buy |
| Chaikin Money Flow: | -2133 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (94.61 - 99.77) | Buy |
| Bollinger Bands (100): | (88.71 - 96.23) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 35.74 | Sell |
| Chaikin Money Flow: | -452975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.4 - 61.5) | Sell |
| Bollinger Bands (100): | (34.32 - 50.52) | Sell |
BBMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 100.71 | Sell |
| 20-day SMA: | 97.35 | Buy |
| 50-day SMA: | 95.13 | Buy |
| 200-day SMA: | 90.43 | Buy |
| 8-day EMA: | 99.72 | Sell |
| 20-day EMA: | 98.1 | Buy |
| 50-day EMA: | 95.67 | Buy |
| 200-day EMA: | 90.23 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.3 | Sell |
| 20-day SMA: | 51.47 | Sell |
| 50-day SMA: | 46.76 | Sell |
| 200-day SMA: | 38.99 | Sell |
| 8-day EMA: | 47.13 | Sell |
| 20-day EMA: | 50.2 | Sell |
| 50-day EMA: | 47.47 | Sell |
| 200-day EMA: | 38.44 | Sell |
JPMorgan BetaBuilders US Mid Cap Eq ETF Earnings Growth & BBMC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
JPMorgan BetaBuilders US Mid Cap Eq ETF Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||